Status
Conditions
Treatments
About
This study is the international multicenter registry for drug-coated balloon treatment for de novo coronary lesion.
Full description
There is lots of evidence that DCBs result in lower rates of restenosis, thrombosis, and better long-term outcomes when used for PCI of in-stent restenosis (ISR) compared to plain old balloon angioplasty (POBA) or additional stenting with drug-eluting stent (DES). DCB-only approach studies for de novo coronary lesion cases are scarce, but a recent registry data suggested it was a feasible and well-tolerated treatment method if the pre-dilation result is good. Therefore, the aim of this study was to evaluate the safety and efficacy in terms of angiographic and clinical outcomes of a DCB-only approach for de novo coronary lesions.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
10,000 participants in 7 patient groups
Loading...
Central trial contact
Eun-Seok Shin
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal